159 331

Cited 5 times in

Application of New Cholesterol Guidelines to the Korean Adult Diabetic Patients

DC Field Value Language
dc.contributor.author김현창-
dc.date.accessioned2018-03-26T16:59:21Z-
dc.date.available2018-03-26T16:59:21Z-
dc.date.issued2015-
dc.identifier.issn1011-8934-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/157049-
dc.description.abstractThe American College of Cardiology and the American Heart Association (ACC/AHA) 2013 joint guidelines for the treatment of hypercholesterolemia expand the indications for statin therapy. This study was performed to estimate the numbers of diabetic patients indicated for statin therapy according to the Third Adult Treatment Panel (ATP-III) of the National Cholesterol Education Program guidelines and the new ACC/AHA guidelines in Korea. We analyzed the data from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010-2012. Patients with diabetes over 30 yr of age were analyzed by the two guidelines. Of the total 1,975 diabetic patients, only 377 (19.1%) were receiving drugs for dyslipidemia. Among 1,598 patients who had not taken any medications for dyslipidemia, 65.6% would be indicated for statin therapy according to the ATP-III guidelines. When we apply the new guidelines, 94.3% would be eligible for statin therapy. Among the total diabetic patients, the new guidelines, compared with the ATP-III guidelines, increase the number eligible for statin therapy from 53.1% to 76.2%. The new guidelines would increase the indication for statin therapy for most diabetic patients. At present, many diabetic patients do not receive appropriate statin therapy. Therefore efforts should be made to develop the Korean guidelines and to ensure that more diabetic patients receive appropriate statin therapy.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisher대한의학회(The Korean Academy of Medical Sciences)-
dc.relation.isPartOfJOURNAL OF KOREAN MEDICAL SCIENCE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAnimals-
dc.subject.MESHCardiology/standards*-
dc.subject.MESHCausality-
dc.subject.MESHComorbidity-
dc.subject.MESHDiabetes Mellitus/drug therapy-
dc.subject.MESHDiabetes Mellitus/epidemiology*-
dc.subject.MESHFemale-
dc.subject.MESHGuideline Adherence/utilization-
dc.subject.MESHHumans-
dc.subject.MESHHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*-
dc.subject.MESHHypercholesterolemia/epidemiology*-
dc.subject.MESHHypercholesterolemia/prevention & control*-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPractice Guidelines as Topic*-
dc.subject.MESHPrevalence-
dc.subject.MESHRepublic of Korea/epidemiology-
dc.subject.MESHRisk Assessment-
dc.subject.MESHUnited States/epidemiology-
dc.titleApplication of New Cholesterol Guidelines to the Korean Adult Diabetic Patients-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Preventive Medicine-
dc.contributor.googleauthorBu Kyung Kim-
dc.contributor.googleauthorHyeon Chang Kim-
dc.contributor.googleauthorKyoung Hwa Ha-
dc.contributor.googleauthorDae Jung Kim-
dc.identifier.doi10.3346/jkms.2015.30.11.1612-
dc.contributor.localIdA01142-
dc.relation.journalcodeJ01517-
dc.identifier.eissn1598-6357-
dc.identifier.pmid26539005-
dc.subject.keywordCholesterol Guidelines-
dc.subject.keywordDiabetes Mellitus-
dc.subject.keywordDyslipidemias-
dc.subject.keywordKorean-
dc.contributor.alternativeNameKim, Hyeon Chang-
dc.contributor.affiliatedAuthorKim, Hyeon Chang-
dc.citation.volume30-
dc.citation.number11-
dc.citation.startPage1612-
dc.citation.endPage1617-
dc.identifier.bibliographicCitationJOURNAL OF KOREAN MEDICAL SCIENCE, Vol.30(11) : 1612-1617, 2015-
dc.identifier.rimsid41357-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.